PSG Konsult Ltd (KST)
Johannesburg Stock Exchange · South Africa · prices in ZAC · close of 27 Oct 2026
Key indicators
| Last close | ZAC 3,008.00 |
|---|---|
| 52-week range | 2,390.00 – 3,750.00 |
| Return, 1 month / 3 months | −5.4% / −10.7% |
| Return, 1 year / 3 years | +21.5% / +113.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 24.1% |
| Worst drawdown (1 year) | -22.2% |
| Average daily value traded | 4,018.39M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PSG Konsult is a South African financial services group based in the Western Cape. It offers wealth management and investment services, short-term insurance broking, and life insurance products, mainly through a network of independent advisers and its own offices. Its customers include individuals, families and businesses seeking financial planning, investment administration and insurance cover. The company also runs asset management activities and provides employee benefits and other financial advice to clients across southern Africa.
PSG Konsult Ltd trades under the code KST on the Johannesburg Stock Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PSG Konsult Ltd (KST) trades on the Johannesburg Stock Exchange in South Africa. It last closed at ZAC 3,008.00 on 27 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 68 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.5% and over the last three months it fell 10.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.4% | ||
| From 52-week high | -16.4% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -10.7% | ||
| 6-month return | 7.1% | ||
| 12-month return, skipping the last month | 28.5% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 24.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.2% | ||
| Liquidity | 70 · Strong | Trades actively. | |
| Average daily value traded | 4,018.39M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.7% |
|---|---|
| 1 month | −5.4% |
| 3 months | −10.7% |
| 6 months | +7.1% |
| 1 year | +21.5% |
| 3 years | +113.9% |
| 5 years | +137.6% |
Signals
| 50-day / 200-day average | 3,120.88 / 2,966.16 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 98.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 May 2023 | ZAC 25.0000 |
| 2 Nov 2022 | ZAC 11.0000 |
| 4 May 2022 | ZAC 22.0000 |
| 27 Oct 2021 | ZAC 10.0000 |
| 5 May 2021 | ZAC 16.5000 |
| 28 Oct 2020 | ZAC 8.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.